Tarsus to Announce Q1 2024 Financial Results on May 8

IRVINE, Calif., May 01, 2024 - Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a company dedicated to addressing unmet medical needs and leveraging innovative science and technology to transform patient care, particularly in eye care, has announced a live webcast scheduled for Wednesday, May 8, 2024, at 1.30 p.m. PT / 4.30 p.m. ET. During this webcast, Tarsus will reveal its financial results for the first quarter of 2024 and provide an update on its corporate developments.

The webcast can be accessed online, and for those unable to join live, a recorded version will be available on the company’s website soon after the event, where it will be archived for at least 90 days.

Tarsus Pharmaceuticals, Inc. is committed to advancing its pipeline to tackle a variety of diseases with significant unmet needs. Their work spans multiple therapeutic areas including eye care, dermatology, and infectious disease prevention. The company’s flagship product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, is FDA-approved in the United States for the treatment of Demodex blepharitis, a common eyelid condition.

Additionally, Tarsus is working on several investigational therapies currently in Phase 2 trials. TP-03 is being developed as a potential treatment for Meibomian Gland Disease, which affects the oil glands in the eyelids and can lead to dry eye symptoms. TP-04 is targeted towards treating rosacea, a chronic skin condition characterized by facial redness and pimples. Another noteworthy project is TP-05, an oral tablet being explored for the prevention of Lyme disease, a tick-borne illness that can have severe health consequences if not treated promptly.

Tarsus Pharmaceuticals' focus remains steadfast on utilizing proven science and cutting-edge technology to create revolutionary treatments that address some of the most pressing medical needs across various therapeutic domains. Their efforts in developing new therapies underscore their commitment to enhancing patient outcomes and advancing medical care.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!